Skip to main content
Clinical Trials/CTRI/2022/03/040844
CTRI/2022/03/040844
Not yet recruiting
Phase 4

Comparative study of Retinal Sensitivity through Microperimetry post intravitreal Avastin vs intravitreal triamcinolone acetonide for diabetic macular edema in pseudophakic eyes

Il0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: H350- Background retinopathy and retinalvascular changes
Sponsor
Il
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Il

Eligibility Criteria

Inclusion Criteria

  • 1\. Central subfield retinal thickness of at least 300um measured by OCT
  • 2\. Centre involving macular edema
  • 3\. Visual acuity between 6/9 to 6/60

Exclusion Criteria

  • 1\. Previous treatment in terms of : \-
  • a) Focal/macular photocoagulation
  • b) Previous intravitreal injection therapy \- Last 3 months
  • c) PRP in the last 6 months
  • 2\. Any medial opacity obscuring the fundus view
  • 3\. Intra ocular pressure \>21mmHg or previous steroid responders
  • 4\. Cataract surgery and YAG capsulotomy in the last 3 months
  • 5\. PDRP patients requiring simultaneous pan\-retinal photocoagulation

Outcomes

Primary Outcomes

Not specified

Similar Trials